Cike Peng

Associate Director of Business Development @ SciClone Pharmaceuticals

About

Over 10 years in healthcare research and industry, covering medical devices, pharma and medtech.

Country

China

City

Jing'an District

Industry

Pharmaceuticals

Skill

Cancer Research, Molecular Biology, Western Blotting, Cell Culture, In Vivo, In Vitro, Epidemiology, qPCR, Animal Models, Cell Biology, Genetics, Science, Microscopy, Flow Cytometry, PCR, Genomics, Cancer, Molecular Genetics, RT-PCR, Life Sciences

Experience

Associate Director of Business Development

SciClone Pharmaceuticals

2024-10 - Present · 2 yrs

Shanghai, China

Associate Director Business Development

Asieris Pharmaceuticals

2022-2 - 2026-1 · 4 yrs

Shanghai, China

Director, Medical Strategy and Real-World Evidence

Yidu Life Science

2020-11 - 2022-2 · 1 yr 4 mos

Shanghai, China

Leading a team of 20+ people covering medical strategy, real-world evidence and health economics research. Leveraging HLT's data network and techniques, the team provides medical strategy consulting services and innovative medical evidence solutions. The current projects cover various stages of the medicinal products, from drug development, peri-launch preparation, market access to long-term life cycle management.

Sr. Associate

Pivotal bioVenture China

2020-8 - 2020-11 · 4 mos

Shanghai, China

Healthcare investment and portfolio management.

Sr. Research Scientist, HEOR/RWE

Eli Lilly and Company

2019-6 - 2020-7 · 1 yr 2 mos

Shanghai

Patient outcomes research and Real World Evidence (RWE) strategic planning and research for oncology products.

Health Economics and Outcomes Research Scientist

Eli Lilly and Company

2017-5 - 2019-6 · 2 yrs 2 mos

Shanghai City, China

Lead peri-Launch HEOR research (Health economics, RWS, PRO, and Epi research) strategic planning and execution for Eli Lilly and alliance oncology products in China.

Clinical Research Specialist

Medtronic

2016-3 - 2017-5 · 1 yr 3 mos

Shanghai City, China

Provide clinical evidence for medical device registration, to claim the compliance to regulatory requirements. Currently supporting the ongoing R&D projects, which requires Clinical Evaluation Reports (CER) and/or clinical trials for CE marking and/or CFDA certificating. Be very glad to share scientific/research experience. Feel free to contact me via inMail.

Researcher

UNIVERSITATS KLINIKUM HEIDELBERG

2012-1 - 2015-10 · 3 yrs 10 mos

Heidelberg Area, Germany

Researcher in the Joint Group of Molecular Epidemiology (DKFZ) and Breast Cancer Molecular Biology (University Heidelberg) Managed 2 patient cohorts with biobanks at Women’s Clinic Heidelberg. Conducted several research projects on breast cancer and ovarian cancer prognostication. 1. Circulating biomarker discovery and validation for diagnosis, prognosis and treatment monitoring of breast cancer. 2. Tissue prognostic marker discovery and validation of breast cancer.

CTL Assistant

Novartis

2010-8 - 2011-3 · 8 mos

Beijing City, China

Assisted CTL in management of regulatory documents, clinical protocols and statistic reports.

Intern Resident

Beijing Shijitan Hospital

2007-1 - 2008-7 · 1 yr 7 mos

Beijing City, China

Conducted physical examinations and performed pre-diagnosis under the supervision of physicians. Rotated in following departments: Cardiovascular, Digestive, General Surgery, Gynecology and Obstetrics and Emergency Room

Education

DKFZ German Cancer Research Center

Epidemiology

2011 - 2015 · 4 yrs

Heidelberg University

Breast cancer biomarker discovery and validation

2011 - 2015 · 4 yrs

Peking University

Toxicology

2009 - 2011 · 2 yrs

Conducted toxicological assessment of several natural products (traditional Chinese medicine) in vivo, evaluated the nephrotoxicity and neurotoxicity.